Shares of Senseonics Holdings, a medical technology company focused on the development and manufacturing of continuous glucose monitoring systems, surged 5.78% in pre-market trading on Friday.
HC Wainwright & Co. maintained its "Buy" rating and a $2.00 price target on Senseonics, indicating potential upside for the stock. The analyst action appears to be driving the pre-market rally.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。